Very positive that the reimbursement amount expected for FebriDx will be on the high end. Makes them much more attractive to health care professionals.
The actual reimbursement rate won't get publicly published until January 2025.
- Forums
- ASX - By Stock
- LDX
- Ann: Q4 FY24 Investor Presentation
LDX
lumos diagnostics holdings limited
Add to My Watchlist
0.00%
!
2.9¢

Ann: Q4 FY24 Investor Presentation, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.70M |
Open | High | Low | Value | Volume |
2.9¢ | 2.9¢ | 2.9¢ | $1.912K | 65.93K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 571666 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 150000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 506666 | 0.028 |
3 | 318288 | 0.027 |
2 | 443000 | 0.026 |
6 | 601153 | 0.025 |
1 | 1238229 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 150000 | 1 |
0.031 | 250309 | 3 |
0.032 | 51725 | 1 |
0.033 | 190000 | 1 |
0.034 | 189253 | 1 |
Last trade - 10.42am 20/06/2025 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |